Global Health Limited (NSE:MEDANTA)
India · Delayed Price · Currency is INR 1,439.90
+10.90 (0.76%)
Nov 12, 2026, 3:29 PM IST
Global Health Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 50,532 | 44,103 | 36,923 | 32,751 | 27,099 | 21,673 |
Other Revenue | - | - | - | - | - | 51.68 |
| 50,532 | 44,103 | 36,923 | 32,751 | 27,099 | 21,725 | |
Revenue Growth | 26.18% | 19.44% | 12.74% | 20.86% | 24.74% | 49.63% |
Cost of Revenue | 24,359 | 21,917 | 17,771 | 15,584 | 13,344 | 11,667 |
Gross Profit | 26,174 | 22,185 | 19,152 | 17,167 | 13,755 | 10,057 |
Selling, General & Admin | 9,017 | 7,796 | 5,984 | 5,199 | 4,213 | 2,920 |
Other Operating Expenses | 5,775 | 4,997 | 3,954 | 3,742 | 3,123 | 2,461 |
Operating Expenses | 17,620 | 15,171 | 12,302 | 10,869 | 8,911 | 6,711 |
Operating Income | 8,554 | 7,014 | 6,850 | 6,298 | 4,844 | 3,346 |
Interest Expense | -1,019 | -780.35 | -640.24 | -725.39 | -774.64 | -789.56 |
Interest & Investment Income | 859.15 | 859.15 | 701.98 | 596.78 | 355.36 | 167.22 |
Currency Exchange Gain (Loss) | -25.57 | -25.57 | 3.7 | -19.19 | -44.36 | 13.62 |
Other Non Operating Income (Expenses) | 70.46 | 13.85 | 7.73 | 15.83 | 20.21 | 41.6 |
EBT Excluding Unusual Items | 8,439 | 7,081 | 6,924 | 6,166 | 4,400 | 2,779 |
Merger & Restructuring Charges | -195.92 | 159.85 | -498.96 | - | - | - |
Gain (Loss) on Sale of Assets | 0.79 | 0.79 | 2.19 | 8.2 | -6.77 | 2.94 |
Asset Writedown | -1.38 | -1.38 | - | - | - | - |
Other Unusual Items | -90.57 | -90.57 | 45.77 | 96.84 | 99.41 | 23.38 |
Pretax Income | 8,152 | 7,150 | 6,473 | 6,271 | 4,493 | 2,806 |
Income Tax Expense | 2,021 | 1,609 | 1,659 | 1,490 | 1,232 | 843.59 |
Earnings From Continuing Operations | 6,131 | 5,541 | 4,813 | 4,781 | 3,261 | 1,962 |
Minority Interest in Earnings | 53.27 | 23.92 | 1.19 | 1.34 | - | - |
Net Income | 6,184 | 5,565 | 4,814 | 4,782 | 3,261 | 1,962 |
Net Income to Common | 6,184 | 5,565 | 4,814 | 4,782 | 3,261 | 1,962 |
Net Income Growth | 10.08% | 15.58% | 0.68% | 46.65% | 66.20% | 581.07% |
Shares Outstanding (Basic) | 269 | 269 | 269 | 269 | 259 | 252 |
Shares Outstanding (Diluted) | 269 | 269 | 269 | 269 | 259 | 252 |
Shares Change | 0.14% | 0.27% | - | 3.52% | 2.81% | 0.13% |
EPS (Basic) | 23.01 | 20.71 | 17.92 | 17.80 | 12.58 | 7.78 |
EPS (Diluted) | 22.96 | 20.66 | 17.92 | 17.80 | 12.57 | 7.77 |
EPS Growth | 9.94% | 15.29% | 0.67% | 41.61% | 61.78% | 581.58% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,891 | -1,238 | 1,072 | 3,335 | 4,085 | 367.87 |
Free Cash Flow Per Share | 7.02 | -4.60 | 3.99 | 12.42 | 15.74 | 1.46 |
Dividend Per Share | - | 0.500 | 0.500 | - | - | - |
Dividend Growth | - | 0% | - | - | - | - |
Gross Margin | 51.80% | 50.30% | 51.87% | 52.42% | 50.76% | 46.29% |
Operating Margin | 16.93% | 15.90% | 18.55% | 19.23% | 17.87% | 15.40% |
Profit Margin | 12.24% | 12.62% | 13.04% | 14.60% | 12.03% | 9.03% |
Free Cash Flow Margin | 3.74% | -2.81% | 2.90% | 10.18% | 15.08% | 1.69% |
EBITDA | 10,928 | 8,939 | 8,552 | 7,809 | 6,188 | 4,483 |
EBITDA Margin | 21.63% | 20.27% | 23.16% | 23.84% | 22.83% | 20.63% |
D&A For EBITDA | 2,374 | 1,925 | 1,702 | 1,511 | 1,344 | 1,136 |
EBIT | 8,554 | 7,014 | 6,850 | 6,298 | 4,844 | 3,346 |
EBIT Margin | 16.93% | 15.90% | 18.55% | 19.23% | 17.87% | 15.40% |
Effective Tax Rate | 24.79% | 22.51% | 25.64% | 23.77% | 27.42% | 30.07% |
Revenue as Reported | 51,575 | 45,089 | 37,713 | 33,498 | 27,592 | 22,058 |
Advertising Expenses | - | - | - | - | 249.07 | 31.18 |